Biocept reports inducement grants under nasdaq listing rule 5635(c)(4)

San diego--(business wire)--biocept, inc. (nasdaq: bioc), a leading provider of molecular diagnostic assays, products and services, today announced that it has granted inducement stock options to purchase an aggregate of 38,250 shares of its common stock to six new employees. these inducement stock options have a grant date of february 28, 2021, and were granted as inducements material to the new employees entering into employment with biocept in accordance with nasdaq listing rule 5635(c)(4).
BIOC Ratings Summary
BIOC Quant Ranking